22246-07-7

Usage

Uses

Used in Pharmaceutical Applications:
7-Amino-3,4-dihydro-1H-quinolin-2-one is used as a pharmaceutical compound for its biological activity. Its unique structure and chemical properties make it a potential candidate for the development of new drugs and therapeutic agents.
Used in Organic Synthesis:
7-Amino-3,4-dihydro-1H-quinolin-2-one is used as a building block in the synthesis of complex organic molecules. Its quinoline core with an amino group and a carbonyl group provides a versatile platform for the creation of various organic compounds with potential applications in different industries.
Used in Research and Development:
7-Amino-3,4-dihydro-1H-quinolin-2-one is used in research and development for its potential applications in various fields. Its unique structural and chemical properties make it an interesting subject for further investigation and exploration of its potential uses and benefits.

InChI:InChI=1/C9H10N2O/c10-7-3-1-6-2-4-9(12)11-8(6)5-7/h1,3,5H,2,4,10H2,(H,11,12)

Upstream product

• 87840-72-0 (E)-ethyl 3-(2,4-dinitrophenyl)acrylate 
• 1613720-64-1 3-(2,4-diamino-phenyl)propionic acid ethyl ester 
• 528-75-6 2,4-dinitrobenzaldehyde 
• 90417-95-1 3-(2,4-dinitrophenyl)propionic acid 
• 840526-76-3 2,4-dinitro-cinnamic acid methyl ester 

Downstream Products

• 81840-01-9 7-(4-Benzoyl-1-piperazinyl)-3,4-dihydrocarbostyril 
• 81839-98-7 7-[4-(4-Methoxybenzoyl)-1-piperazinyl]-3,4-dihydrocarbostyril 
• 920978-65-0 N-(2-oxo-1,2,3,4-tetrahydroquinol-7-yl)-1-[(3-fluorophenyl)methyl]-1H-pyrrolo[2,3-b]pyridine-2-carboxamide 
• 153856-89-4 7-amino-1,2,3,4-tetrahydroquinoline 

Relevant academic research and scientific papers

TRIAZINONE COMPOUNDS

The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treati

ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein R1, R2, Ar, m and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

CONDENSED HETEROCYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I) wherein R1, A, B, D, E, G, Q, Ar, n, m, and p are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

ACYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein R1, R2, R5, Q, G, Ar, m, and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): formula (I) wherein Cy is selected from formula (Il) and wherein R1, R2, R3, Q, G, Ar, m, n and p are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

PYRROLIDINE-SUBSTITUTED AZAINDOLE COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein R1, R2, A, B, D, E, G, Ar, and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

3' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein Q, R1, R4, m and Ar are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

4' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein R1, R2, R5, R6, B, D, E, G, Q, x and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein R1—R4 A, B, D, E, and G are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY

The present disclosure provides compounds having affinity for the 5HT6 receptor which are of the formula (I), wherein R1-R3 A, B, D, E, G, Q, and x are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.